1,1-dichloroethene decreases expression ISO RGD:10671 6480464 vinylidene chloride results in decreased expression of GNMT mRNA CTD PMID:26682919 1-naphthyl isothiocyanate decreases expression ISO RGD:2719 6480464 1-Naphthylisothiocyanate results in decreased expression of GNMT mRNA CTD PMID:30723492 17alpha-ethynylestradiol multiple interactions ISO RGD:10671 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GNMT mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:2719 6480464 Ethinyl Estradiol results in increased expression of GNMT mRNA CTD PMID:12082028 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GNMT mRNA CTD PMID:20106945 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression EXP 6480464 Metribolone results in increased expression of GNMT mRNA CTD PMID:17010675 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of GNMT mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:10671 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10671 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of GNMT mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GNMT mRNA CTD PMID:16214954 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GNMT mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GNMT mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2719 6480464 Tetrachlorodibenzodioxin results in decreased expression of GNMT mRNA CTD PMID:16054898 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2719 6480464 Tetrachlorodibenzodioxin affects the expression of GNMT mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GNMT mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10671 6480464 Tetrachlorodibenzodioxin results in decreased expression of GNMT mRNA CTD PMID:18796159 , PMID:19770486 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:2719 6480464 Butylated Hydroxytoluene results in increased expression of GNMT mRNA CTD PMID:12082028 2-nitrofluorene decreases expression ISO RGD:2719 6480464 2-nitrofluorene results in decreased expression of GNMT mRNA CTD PMID:14600272 3-chloropropane-1,2-diol decreases expression ISO RGD:2719 6480464 alpha-Chlorohydrin results in decreased expression of GNMT protein CTD PMID:26597043 3-methylcholanthrene multiple interactions ISO RGD:2719 6480464 [Methylcholanthrene co-treated with GNMT protein] results in increased expression of CYP1A1 mRNA CTD PMID:9261130 3-methylcholanthrene decreases expression EXP 6480464 Methylcholanthrene results in decreased expression of GNMT mRNA CTD PMID:22100608 3H-1,2-dithiole-3-thione decreases expression ISO RGD:2719 6480464 1, 2-dithiol-3-thione results in decreased expression of GNMT mRNA CTD PMID:19162173 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO RGD:2719 6480464 4-N-methyl-N-nitrosamino-1-3-pyridyl-1-butanone results in decreased expression of GNMT mRNA CTD PMID:14600272 4-hydroxyphenyl retinamide increases expression ISO RGD:10671 6480464 Fenretinide results in increased expression of GNMT mRNA CTD PMID:28973697 5-methyltetrahydrofolic acid affects binding ISO RGD:2719 6480464 GNMT protein binds to 5-methyltetrahydrofolate CTD PMID:17158459 acetamide decreases expression ISO RGD:2719 6480464 acetamide results in decreased expression of GNMT mRNA CTD PMID:31881176 aflatoxin B1 multiple interactions EXP 6480464 GNMT inhibits the reaction [Aflatoxin B1 results in increased abundance of aflatoxin B1-DNA adduct] CTD PMID:19146867 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of GNMT mRNA CTD PMID:22100608 more ... aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GNMT mRNA CTD PMID:22100608 aflatoxin B1 decreases expression ISO RGD:10671 6480464 Aflatoxin B1 results in decreased expression of GNMT mRNA CTD PMID:19770486 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of GNMT protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:2719 6480464 Aflatoxin B1 results in decreased expression of GNMT mRNA CTD PMID:14600272 , PMID:33354967 aflatoxin B1 affects localization EXP 6480464 GNMT protein affects the localization of Aflatoxin B1 CTD PMID:19146867 aflatoxin B1 decreases response to substance EXP 6480464 GNMT results in decreased susceptibility to Aflatoxin B1 CTD PMID:19146867 aflatoxin M1 increases secretion EXP 6480464 GNMT results in increased secretion of Aflatoxin M1 CTD PMID:19146867 aflatoxin Q1 decreases secretion EXP 6480464 GNMT results in decreased secretion of aflatoxin Q1 CTD PMID:19146867 ammonium chloride affects expression ISO RGD:2719 6480464 Ammonium Chloride affects the expression of GNMT mRNA CTD PMID:16483693 aristolochic acid multiple interactions ISO RGD:2719 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of GNMT mRNA CTD PMID:23912714 Aroclor 1254 decreases expression ISO RGD:2719 6480464 Chlorodiphenyl 54% Chlorine results in decreased expression of GNMT mRNA CTD PMID:18178546 benzo[a]pyrene decreases expression ISO RGD:10671 6480464 Benzoapyrene results in decreased expression of GNMT mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation EXP 6480464 Benzoapyrene results in decreased methylation of GNMT promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of GNMT mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:10671 6480464 Benzoapyrene results in increased expression of GNMT mRNA CTD PMID:21569818 benzo[a]pyrene multiple interactions ISO RGD:2719 6480464 [Benzoapyrene co-treated with GNMT protein] results in increased expression of CYP1A1 mRNA more ... CTD PMID:21445860 , PMID:9261130 benzo[a]pyrene affects binding ISO RGD:2719 6480464 Benzoapyrene binds to GNMT protein CTD PMID:9261130 benzo[e]pyrene multiple interactions ISO RGD:2719 6480464 [benzoepyrene co-treated with GNMT protein] results in increased expression of CYP1A1 mRNA CTD PMID:9261130 bisphenol A affects expression ISO RGD:2719 6480464 bisphenol A affects the expression of GNMT mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GNMT mRNA CTD PMID:30903817 bromobenzene affects binding ISO RGD:2719 6480464 bromobenzene metabolite binds to GNMT protein CTD PMID:17305373 cadmium dichloride decreases expression ISO RGD:2719 6480464 Cadmium Chloride results in decreased expression of GNMT mRNA CTD PMID:25993096 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of GNMT mRNA CTD PMID:21592394 calcitriol multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GNMT mRNA CTD PMID:21592394 captan decreases expression ISO RGD:10671 6480464 Captan results in decreased expression of GNMT mRNA CTD PMID:31558096 carbon nanotube affects expression ISO RGD:10671 6480464 Nanotubes, Carbon affects the expression of GNMT mRNA CTD PMID:25554681 carbon nanotube multiple interactions ISO RGD:10671 6480464 [Nanotubes, Carbon co-treated with Polyethylene Glycols] results in increased expression of GNMT protein CTD PMID:28807745 carbon nanotube decreases expression ISO RGD:10671 6480464 Nanotubes, Carbon analog results in decreased expression of GNMT mRNA CTD PMID:25554681 chloroprene increases expression ISO RGD:10671 6480464 Chloroprene results in increased expression of GNMT mRNA CTD PMID:23125180 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of GNMT mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of GNMT mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:10671 6480464 Clofibrate results in decreased expression of GNMT mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:10671 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GNMT mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GNMT mRNA] CTD PMID:17585979 copper atom decreases expression ISO RGD:2719 6480464 Copper results in decreased expression of GNMT mRNA CTD PMID:22465980 copper(0) decreases expression ISO RGD:2719 6480464 Copper results in decreased expression of GNMT mRNA CTD PMID:22465980 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of GNMT mRNA CTD PMID:19549813 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of GNMT mRNA CTD PMID:20106945 , PMID:25562108 cylindrospermopsin decreases expression EXP 6480464 cylindrospermopsin results in decreased expression of GNMT mRNA CTD PMID:23726867 dexamethasone increases expression ISO RGD:2719 6480464 Dexamethasone results in increased expression of GNMT mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:2719 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of GNMT mRNA] CTD PMID:20032058 dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of GNMT mRNA CTD PMID:28302478 elemental selenium affects activity ISO RGD:2719 6480464 Selenium affects the activity of GNMT protein CTD PMID:16632891 endosulfan multiple interactions EXP 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GNMT mRNA CTD PMID:26159488 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GNMT mRNA CTD PMID:26159488 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of GNMT mRNA CTD PMID:25572481 finasteride decreases expression ISO RGD:2719 6480464 Finasteride results in decreased expression of GNMT mRNA CTD PMID:24136188 flavonoids decreases expression ISO RGD:2719 6480464 Flavonoids results in decreased expression of GNMT mRNA CTD PMID:18035473 flutamide decreases expression ISO RGD:2719 6480464 Flutamide results in decreased expression of GNMT mRNA CTD PMID:24136188 folic acid affects activity ISO RGD:2719 6480464 Folic Acid affects the activity of GNMT protein CTD PMID:16632891 folic acid increases expression ISO RGD:10671 6480464 Folic Acid results in increased expression of GNMT mRNA, Folic Acid results in increased expression of GNMT protein CTD PMID:30920123 folic acid multiple interactions ISO RGD:2719 6480464 Folic Acid inhibits the reaction [Streptozocin results in increased activity of GNMT protein] CTD PMID:16835399 fructose multiple interactions ISO RGD:10671 6480464 [Dietary Fats co-treated with Fructose] results in increased expression of GNMT mRNA CTD PMID:29416063 fumonisin B1 decreases expression ISO RGD:10671 6480464 fumonisin B1 results in decreased expression of GNMT mRNA CTD PMID:16221962 furan decreases expression ISO RGD:2719 6480464 furan results in decreased expression of GNMT mRNA CTD PMID:25539665 gefitinib multiple interactions ISO RGD:10671 6480464 [gefitinib co-treated with naphthalene] affects the expression of GNMT mRNA CTD PMID:20935109 genistein decreases expression ISO RGD:2719 6480464 Genistein results in decreased expression of GNMT mRNA CTD PMID:12075121 genistein decreases expression ISO RGD:10671 6480464 Genistein results in decreased expression of GNMT mRNA CTD PMID:32186404 glafenine decreases expression ISO RGD:2719 6480464 Glafenine results in decreased expression of GNMT mRNA CTD PMID:24136188 gliotoxin decreases expression ISO RGD:2719 6480464 Gliotoxin results in decreased expression of GNMT mRNA CTD PMID:18346771 GW 4064 multiple interactions ISO RGD:10671 6480464 NR0B2 protein promotes the reaction [GW 4064 results in decreased expression of GNMT mRNA] CTD PMID:29416063 GW 4064 decreases expression ISO RGD:10671 6480464 GW 4064 results in decreased expression of GNMT mRNA CTD PMID:29416063 Lasiocarpine decreases expression EXP 6480464 lasiocarpine results in decreased expression of GNMT mRNA CTD PMID:32234424 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of GNMT mRNA CTD PMID:28988120 MeIQx decreases expression EXP 6480464 2-amino-3 more ... CTD PMID:20816883 , PMID:22100608 metformin decreases expression ISO RGD:2719 6480464 Metformin results in decreased expression of GNMT mRNA CTD PMID:31324951 methapyrilene increases expression ISO RGD:2719 6480464 Methapyrilene results in increased expression of GNMT protein CTD PMID:30467583 methyl methanesulfonate decreases expression EXP 6480464 Methyl Methanesulfonate results in decreased expression of GNMT mRNA CTD PMID:22100608 N-nitrosodiethylamine decreases expression ISO RGD:2719 6480464 Diethylnitrosamine results in decreased expression of GNMT mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions ISO RGD:2719 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of GNMT mRNA CTD PMID:28943392 N-nitrosodiethylamine decreases expression ISO RGD:10671 6480464 Diethylnitrosamine results in decreased expression of GNMT mRNA CTD PMID:24535843 N-nitrosodimethylamine decreases expression ISO RGD:2719 6480464 Dimethylnitrosamine results in decreased expression of GNMT mRNA CTD PMID:14600272 N-Nitrosopyrrolidine decreases expression EXP 6480464 N-Nitrosopyrrolidine results in decreased expression of GNMT mRNA CTD PMID:32234424 naphthalene multiple interactions ISO RGD:10671 6480464 [gefitinib co-treated with naphthalene] affects the expression of GNMT mRNA CTD PMID:20935109 nefazodone decreases expression ISO RGD:2719 6480464 nefazodone results in decreased expression of GNMT mRNA CTD PMID:24136188 nimesulide decreases expression ISO RGD:2719 6480464 nimesulide results in decreased expression of GNMT mRNA CTD PMID:24136188 O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of GNMT mRNA CTD PMID:32234424 ochratoxin A decreases expression ISO RGD:2719 6480464 ochratoxin A results in decreased expression of GNMT mRNA CTD PMID:17483316 ozone increases expression ISO RGD:2719 6480464 Ozone results in increased expression of GNMT mRNA CTD PMID:25838073 paracetamol multiple interactions ISO RGD:10671 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GNMT mRNA more ... CTD PMID:17585979 , PMID:29246445 paracetamol decreases expression ISO RGD:10671 6480464 Acetaminophen results in decreased expression of GNMT mRNA CTD PMID:29246445 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GNMT mRNA CTD PMID:26690555 , PMID:29067470 paracetamol affects expression ISO RGD:10671 6480464 Acetaminophen affects the expression of GNMT mRNA CTD PMID:17562736 paracetamol affects expression ISO RGD:2719 6480464 Acetaminophen affects the expression of GNMT mRNA, Acetaminophen affects the expression of GNMT protein CTD PMID:16687475 , PMID:19103213 paracetamol decreases expression ISO RGD:2719 6480464 Acetaminophen results in decreased expression of GNMT mRNA CTD PMID:18346771 paraquat increases expression ISO RGD:10671 6480464 Paraquat results in increased expression of GNMT mRNA CTD PMID:21463325 perfluorononanoic acid decreases expression EXP 6480464 perfluorononanoic acid results in decreased expression of GNMT mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:2719 6480464 perfluorooctane sulfonic acid results in decreased expression of GNMT mRNA CTD PMID:18692542 phenformin increases expression ISO RGD:2719 6480464 Phenformin results in increased expression of GNMT mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:2719 6480464 Phenobarbital results in decreased expression of GNMT mRNA CTD PMID:19162173 phenobarbital increases expression ISO RGD:2719 6480464 Phenobarbital results in increased expression of GNMT mRNA CTD PMID:12082028 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in decreased expression of GNMT mRNA CTD PMID:22100608 piperonyl butoxide decreases expression ISO RGD:2719 6480464 Piperonyl Butoxide results in decreased expression of GNMT mRNA CTD PMID:22484513 pirinixic acid decreases expression ISO RGD:2719 6480464 pirinixic acid results in decreased expression of GNMT mRNA CTD PMID:17164430 , PMID:19162173 pirinixic acid decreases expression ISO RGD:10671 6480464 pirinixic acid results in decreased expression of GNMT mRNA, pirinixic acid results in decreased expression of GNMT protein CTD PMID:15226431 more ... pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:2719 6480464 Pregnenolone Carbonitrile results in decreased expression of GNMT mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:10671 6480464 Pregnenolone Carbonitrile results in increased expression of GNMT mRNA CTD PMID:28903501 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of GNMT mRNA CTD PMID:21632981 rotenone affects expression ISO RGD:2719 6480464 Rotenone affects the expression of GNMT mRNA CTD PMID:28374803 selenium atom affects activity ISO RGD:2719 6480464 Selenium affects the activity of GNMT protein CTD PMID:16632891 senecionine increases expression EXP 6480464 senecionine results in increased expression of GNMT mRNA CTD PMID:26100227 sodium arsenite increases expression ISO RGD:10671 6480464 sodium arsenite results in increased expression of GNMT protein CTD PMID:29044176 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of GNMT mRNA CTD PMID:29301061 sodium dichromate decreases expression ISO RGD:2719 6480464 sodium bichromate results in decreased expression of GNMT mRNA CTD PMID:22561333 , PMID:25993096 streptozocin multiple interactions ISO RGD:2719 6480464 Folic Acid inhibits the reaction [Streptozocin results in increased activity of GNMT protein] CTD PMID:16835399 streptozocin increases expression ISO RGD:2719 6480464 Streptozocin results in increased expression of GNMT mRNA, Streptozocin results in increased expression of GNMT protein CTD PMID:16835399 streptozocin increases activity ISO RGD:2719 6480464 Streptozocin results in increased activity of GNMT protein CTD PMID:16835399 sulindac decreases expression ISO RGD:2719 6480464 Sulindac results in decreased expression of GNMT mRNA CTD PMID:24136188 tebuconazole decreases expression EXP 6480464 tebuconazole results in decreased expression of GNMT mRNA CTD PMID:30458266 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GNMT mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:2719 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of GNMT mRNA] CTD PMID:20032058 testosterone increases expression EXP 6480464 Testosterone results in increased expression of GNMT mRNA CTD PMID:21592394 tetrachloromethane decreases expression ISO RGD:2719 6480464 Carbon Tetrachloride results in decreased expression of GNMT mRNA CTD PMID:18346771 tetrachloromethane decreases expression ISO RGD:10671 6480464 Carbon Tetrachloride results in decreased expression of GNMT mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide decreases expression ISO RGD:2719 6480464 Thioacetamide results in decreased expression of GNMT mRNA CTD PMID:23411599 thioacetamide multiple interactions ISO RGD:2719 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of GNMT mRNA CTD PMID:28943392 titanium dioxide decreases expression ISO RGD:10671 6480464 titanium dioxide results in decreased expression of GNMT mRNA CTD PMID:23557971 triazines multiple interactions ISO RGD:10671 6480464 Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of GNMT mRNA] CTD PMID:27469509 trichloroethene decreases expression ISO RGD:10671 6480464 Trichloroethylene results in decreased expression of GNMT mRNA CTD PMID:19448997 triphenyl phosphate decreases expression ISO RGD:2719 6480464 triphenyl phosphate results in decreased expression of GNMT mRNA CTD PMID:30589522 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of GNMT mRNA CTD PMID:25572481 urethane decreases expression EXP 6480464 Urethane results in decreased expression of GNMT mRNA CTD PMID:28818685 valdecoxib decreases expression ISO RGD:2719 6480464 valdecoxib results in decreased expression of GNMT mRNA CTD PMID:24136188 vancomycin increases expression ISO RGD:10671 6480464 Vancomycin results in increased expression of GNMT mRNA CTD PMID:18930951